|
|
|
Volumn 29, Issue 3, 1996, Pages 378-379
|
|
Selectivity at the molecular level of the classical and newer α1-adrenoceptor antagonists in the treatment of benign prostatic hyperplasia: The concept of uroselectivity
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2 [[2 (2,6 DIMETHOXYPHENOXY)ETHYL]AMINOMETHYL] 1,4 BENZODIOXAN;
5 METHYLURAPIDIL;
ALFUZOSIN;
ALPHA 1 ADRENERGIC RECEPTOR;
ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT;
ALPHA 1A ADRENERGIC RECEPTOR;
BUNAZOSIN;
DOXAZOSIN;
INDORAMIN;
OXYMETAZOLINE;
PHENTOLAMINE;
PRAZOSIN;
RECEPTOR SUBTYPE;
TAMSULOSIN;
TERAZOSIN;
ANIMAL CELL;
CONFERENCE PAPER;
DRUG POTENCY;
DRUG RECEPTOR BINDING;
DRUG SELECTIVITY;
HUMAN;
HUMAN CELL;
NONHUMAN;
PRIORITY JOURNAL;
PROSTATE HYPERTROPHY;
RECEPTOR AFFINITY;
|
|
EID: 0029920873
PISSN: 03022838
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (1)
|
|
References (0)
|
